Patent · US Active

Multispecific antigens binding fragments and multispecific antibodies

US11945879B2 · kind B2 · utility

0Cited by
1References
3Claims
0Family size

Assignees

Inventors

Key dates

Filing dateAug 18, 2020
Grant dateApr 2, 2024
Priority date—
Expiry dateApr 17, 2042

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/732
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The invention relates to multispecific antibody constructs comprising Fab fragments having mutations at the interface of the CH1 and CL domains, said mutations preventing heavy chain/light chain mispairing.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.